Quest Diagnostics (DGX) revenue: $11B
Quest Diagnostics reported $11B of revenue for the year ended Dec 31, 2025, up 11.8% from $9.9B a year earlier.
From Quest Diagnostics's filings with the SEC · Read the filing · DGX stock page
Quest Diagnostics revenue by year
#410 of 3,622 US companies by revenue · See the full ranking
| Year ended | Revenue | Change |
|---|---|---|
| Dec 31, 2025 | $11B | +12% |
| Dec 31, 2024 | $9.9B | +7% |
| Dec 31, 2023 | $9.3B | -6% |
| Dec 31, 2022 | $9.9B | -8% |
| Dec 31, 2021 | $10.8B | – |
Revenue of similar companies
Companies in the same industry as Quest Diagnostics, by SEC industry code, with the closest revenue. Each name opens the same page for that company.
| Company | Revenue, latest year | Year ended |
|---|---|---|
| Labcorp | $14B | Dec 31, 2025 |
| Quest Diagnostics | $11B | Dec 31, 2025 |
| Fortrea | $2.7B | Dec 31, 2025 |
| Natera | $2.3B | Dec 31, 2025 |
| RadNet | $2B | Dec 31, 2025 |
| Guardant Health | $982M | Dec 31, 2025 |
| Caris Life Sciences | $812M | Dec 31, 2025 |
Questions and answers
What is Quest Diagnostics's revenue?
Quest Diagnostics reported $11B of revenue for the year ended Dec 31, 2025, up 11.8% from $9.9B a year earlier.
Numbers as reported in Quest Diagnostics's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology